There were two further phase IIa studies evaluating cotadutide with the first one showing that it reduced glucose levels in those with obesity and T2DM with the mechanism being greater insulin secretion and delayed gastric emptying [46]
Weight gain after stopping GLP-1 drugs (by Patricia Toro, MD MPH) November 21, 2023 This post guest-authored by my colleague Patricia Toro, MD MPH Source: Rubino, et al JAMA March, 2021 LINK The GLP-1 drug class has been shown to be effective at supporting weight loss, from an average of 15% for Wegovy (semaglutide) to 21% for the newly- approved Zepbound (tirzepatide)
Click here to report it, or see our DMCA policy.
Perioperative management : According to 2024 multi-society guidance, most patients can continue GLP-1 receptor agonists perioperatively, though individualized risk assessment is recommended, particularly for major gastrointestinal surgery or procedures with high aspiration risk
When paired with collagen, it helps maintain the cushion between your bones, allowing for smoother, more comfortable movement